Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00986180 · ClinicalTrials.gov registry record · Phase 3
NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain
A Phase 3 study, sponsored by Ortho-McNeil Janssen Scientific Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 667
- Enrollment target
NCT00986180 is a Phase 3 study that has completed, run by Ortho-McNeil Janssen Scientific Affairs. The registered enrollment target is 667 participants.
The verdict
NCT00986180, a Phase 3 study, has completed, sponsored by Ortho-McNeil Janssen Scientific Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 667 participants
- Enrollment target
Study Summary
Evaluate how NUCYNTA (tapentadol) immediate release (IR) compares with oxycodone IR in the treatment of acute low back pain.
Interventions
- DRUG Oxycodone IR
- DRUG NUCYNTA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 667 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00986180
The ClinicalTrials.gov registry entry for NCT00986180 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 667 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ortho-McNeil Janssen Scientific Affairs, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oxycodone IR is the first listed.
NCT00986180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00986180 about?
NCT00986180 is a clinical study titled "NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain". Evaluate how NUCYNTA (tapentadol) immediate release (IR) compares with oxycodone IR in the treatment of acute low back pain.
What is the current status of trial NCT00986180?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 667 participants. The study started on 2009-09. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00986180?
The interventions under investigation include: Oxycodone IR (DRUG), NUCYNTA (DRUG).
Who is sponsoring clinical trial NCT00986180?
This trial is sponsored by Ortho-McNeil Janssen Scientific Affairs, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.